| 中文别名： |
2,6-双[(3aR,8aS)-(+)-8H-茚[1,2-d]恶唑啉-2-基]吡啶;2,6-双[(3aR,8aS)-(+)-8H-茚并[1,2-d]噁唑啉-2-基)吡啶;[(3aR,8aS)-(＋)-8H-茚[1,2-d]恶唑啉-2-基]吡啶;1,1-二乙基己烷;2,6-双((3ar,8as)-8,8a-二氢-3ah-茚并[1,2-d]噁唑-2-基)吡啶;2,6-双[(3aR,8aS)-(+)-8H-茚并[1,2-d]噁唑啉-2-基]吡啶;(3aR,3′aR,8aS,8′aS)-2,2′-(2,6-吡啶二基)双[3a,8a-二氢-8H-茚并[1,2-d]噁唑;2,6-双[(3aR,8aS)-(+)-8H-茚并[1,2-d]恶唑啉-2-基]吡啶 |
| 英文别名： |
2,6-Bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)pyridine;2,6-Bis[(3aR,8aS)-(+)-8H-indeno[1,2-d]oxazolin-2-yl)pyridine;(3aS,8bR)-2-[6-[(3aS,8bR)-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazol-2-yl]pyridin-2-yl]-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazole;2,6-BIS((3AR,8AS)-8H-INDENO(1,2-D) OXAZOLIN-2-YL)PYRIDINE;8H-Indeno[1,2-d]oxazole,2,2'-(2,6-pyridinediyl)bis[3a,8a-dihydro-, (3aR,3'aR,8aS,8'aS)-;2,4-MESITYLENEDISULFONYL DICHLORIDE;(3aR,8aS)-in-pybox;357209-32-6;D82311;(3aR,3'aR,8aS,8'aS)-2,2'-(2,6-Pyridinediyl)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 98% (99% ee);NSC-819326;CS-0035259;26-Bis[(3aR8aS)-(+)-8H-indeno[12-d]oxazolin-2-yl)pyridine;AKOS016843569;2,6-BIS[(3AR,8AS)-(+)-8H-INDENO[1,2-D]OXAZOLIN-2-YL]PYRIDINE;(R,S)-In-Pybox;BS-22816;MFCD09265074;DTXSID20479118;2,6-bis((3aR,8aS)-3a,8a-dihydro-8H-indeno[1,2-d]oxazol-2-yl)pyridine;NSC819326;2,6-Bis[(3aR,8aS)-(+)-8H-indeno[1,2-d]oxazolin-2-yl)pyridine, >=94% |
沪公网安备 
